These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 8195931)
1. Expression of bcl-2 gene product in neuroblastoma. Ramani P; Lu QL J Pathol; 1994 Mar; 172(3):273-8. PubMed ID: 8195931 [TBL] [Abstract][Full Text] [Related]
2. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein. Krajewski S; Chatten J; Hanada M; Reed JC Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790 [TBL] [Abstract][Full Text] [Related]
4. Expression of mdr1/P-glycoprotein and p110 in neuroblastoma. Ramani P; Dewchand H J Pathol; 1995 Jan; 175(1):13-22. PubMed ID: 7891222 [TBL] [Abstract][Full Text] [Related]
5. Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma. Mejía C; Navarro S; Colamonici OR; Pellín A; Castel V; Llombart-Bosch A Oncol Rep; 1999; 6(1):149-53. PubMed ID: 9864419 [TBL] [Abstract][Full Text] [Related]
6. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer. Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896 [TBL] [Abstract][Full Text] [Related]
8. Bcl-2 expression in neuroblastoma is differentially regulated by differentiation inducers. Kim CJ; Kim HO; Choe YJ; Lee YA; Kim CW Anticancer Res; 1995; 15(5B):1997-2000. PubMed ID: 8572591 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material]. Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575 [TBL] [Abstract][Full Text] [Related]
10. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis. Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma. Soini Y; Kinnula V; Kaarteenaho-Wiik R; Kurttila E; Linnainmaa K; Pääkkö P Clin Cancer Res; 1999 Nov; 5(11):3508-15. PubMed ID: 10589765 [TBL] [Abstract][Full Text] [Related]
12. Aberrant bcl-2 and bax protein expression related to chemotherapy response in neuroblastoma. Gallo G; Giarnieri E; Bosco S; Cappelli C; Alderisio M; Giovagnoli MR; Giordano A; Vecchione A Anticancer Res; 2003; 23(1B):777-84. PubMed ID: 12680183 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of Bcl-2 and Bax may enhance neuroblastoma survival. Beierle EA; Dai W; Iyengar R; Langham MR; Copeland EM; Chen MK J Pediatr Surg; 2003 Mar; 38(3):486-91. PubMed ID: 12632373 [TBL] [Abstract][Full Text] [Related]
14. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti MA J Pathol; 1994 Apr; 172(4):337-42. PubMed ID: 8207614 [TBL] [Abstract][Full Text] [Related]
15. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study. Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329 [TBL] [Abstract][Full Text] [Related]
16. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748 [TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [TBL] [Abstract][Full Text] [Related]
18. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients? Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882 [TBL] [Abstract][Full Text] [Related]
19. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse. Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743 [TBL] [Abstract][Full Text] [Related]